Tus kws kho mob
P20-16 Addition of Uptravi ® and Adempas ® to Existing Drug-Related Prior Authorization Program
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 04, 2016
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 3291 - 3300 ntawm 3669
Tus kws kho mob
P10-16 New Drug-Related Prior Authorization Criteria for Gattex
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 08, 2016
Tus kws kho mob
P50-17 Provider Data Accuracy and Identified Lack of Claim Submissions
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 25, 2017
Tus kws kho mob
P30-16 New Prior Authorization Requirement for Lyme Disease: Diagnostic Testing and Intravenous Antibiotic Therapy
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 07, 2016
Tus kws kho mob
P5-17 Updated: Third Party Payments of Premium and/or Cost-Sharing
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 08, 2017
Tus kws kho mob
P8-16 Personal Care Assistance (PCA) Service UMPI Delay Process
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 08, 2016
Tus kws kho mob
P16-16 Blue Cross Contracts with SecureCare to Manage the Chiropractic Network
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 22, 2016
Tus kws kho mob
P4-16 New Drug-Related Prior Authorization Criteria for Myalept
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 08, 2016
Tus kws kho mob
P11-16 New Drug-Related Prior Authorization Criteria: Idiopathic P ulmonary Fibrosis Prior Authorization with Quantity Limit Criteria: Esbriet ® and Ofev ®
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 08, 2016
Tus kws kho mob
P7-16 Addition of Drugs to the Self-Administered Oral Oncology Prior Authorization with Quantity Limit Program
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 27, 2016